IGF::OT::IGF VALIDATION OF MOBILE TECHNOLOGIES FOR CLINICAL ASSESSMENT
IGF::OT::IGF VALIDATION OF MOBILE TECHNOLOGIES FOR CLINICAL ASSESSMENT
IGF::OT::IGF 临床评估移动技术验证
批准号：
9148278
负责人：
KERRY EVERS
金额：
$149.59万
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
项目状态：
已结题
起止时间：
2015-09-15 至 2017-09-14
关键词：
AdoptionBehavioralBehavioral ResearchCancer ControlCancer SurvivorCellular PhoneCessation of lifeChronic DiseaseClinicalClinical ResearchClinical assessmentsComputer softwareDiagnosticDivision of Cancer Control and Population SciencesEvaluationHealthHealth TechnologyIncidenceInterventionMalignant NeoplasmsMissionMonitorPhaseQuality of lifeRiskRisk FactorsSmall Business Innovation Research GrantTechnologyTreatment EfficacyValidationWireless Technologycancer carecancer preventionclinical practicecostfollow-upimprovedinnovationlifestyle interventionscreeningsensortool
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SBIR Direct-to-Phase II Topic 340 encourages validation of mobile/wireless tools to support cancer prevention & control in clinical behavioral applications. Technologies may include wireless sensors, smartphone applications, behavioral analytics and decision support software or integrated platforms for health assessment, monitoring or intervention delivery. This topic is intended to clinically validate recently developed but not yet validated tools, in order to expand evidence of commercial potential and value.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF FY15- IWIN; NAVIGATING YOUR PATH TO WELL BEING; SBIR PHASE II. BASE AWARD. PERIOD OF PERFORMANCE 9/1/2015-8/31/2017
-
批准号：9162200
-
项目类别：
-
资助金额：$99.95万
-
财政年份：2015
-
负责人：KERRY EVERS
-
依托单位：
IGF::OT::IGF High-Impact Substance Abuse Prevention Technologies. SBIR Phase I. Period of Performance 7/16/2014-1/15/2015
-
批准号：8949035
-
项目类别：
-
资助金额：$14.99万
-
财政年份：2014
-
负责人：KERRY EVERS
-
依托单位：
国内基金
海外基金
Behavioral Insights on Cooperation in Social Dilemmas
-
批准号：--
-
项目类别：外国优秀青年学者研究基金项目
-
资助金额：--
-
批准年份：2024
-
负责人：LIEN，Jaimie Wei-Hung
-
依托单位：
